The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy

Activation of the Hippo transducer TAZ is emerging as a novel oncogenic route in breast cancer and it has been associated with breast cancer stem cells. Additionally, TAZ expression has been linked with HER-2 positivity. We investigated the association between TAZ expression and pathological complet...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncotarget
Главные авторы: Vici, Patrizia, Mottolese, Marcella, Pizzuti, Laura, Barba, Maddalena, Sperati, Francesca, Terrenato, Irene, Benedetto, Anna Di, Natoli, Clara, Gamucci, Teresa, Angelucci, Domenico, Ramieri, Maria Teresa, Lauro, Luigi Di, Sergi, Domenico, Bartucci, Monica, Dattilo, Rosanna, Pagliuca, Alfredo, Maria, Ruggero De, Maugeri-Saccà, Marcello
Формат: Artigo
Язык:Inglês
Опубликовано: Impact Journals LLC 2014
Предметы:
Clinical Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4259424/
https://ncbi.nlm.nih.gov/pubmed/25294813
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы